Dysfunction of PI3K/Akt/GSK‐3β signaling pathway will not only lead to insulin deficiency and insulin resistance in DM patients, but also lead to tau hyperphosphorylation in the brain of AD patents.58, 59. Here, AKT1 is linked to Insulin resistance.